Last reviewed · How we verify
NCT04246385
Implementing a CO-OP Group in the Day Rehab Setting: A Pilot Study.
NA trial testing CO-OP Group in Cerebral Vascular Accident in 11 participants. Completed in 30 November 2020.
30 November 2020
Quick facts
| Lead sponsor | Shirley Ryan AbilityLab |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 11 |
| Start date | 3 January 2020 |
| Primary completion | 30 November 2020 |
| Estimated completion | 30 November 2020 |
| Sites | 1 location across United States |
Drugs / interventions tested
- CO-OP Group
Conditions studied
- Cerebral Vascular Accident — all drugs for Cerebral Vascular Accident →
Sponsor
Shirley Ryan AbilityLab — full company profile →
Who can join
18 and older, any sex, with Cerebral Vascular Accident. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is pilot study will examine the effectiveness of a group curriculum developed from the CO-OP approach. This study has two aims, the first is to standardize the group curriculum and the second is to compare the data from the group receiving CO-OP group curriculum to the control group. Primary methods will include a standardized observation of occupational performance, an semi-structured interview measuring performance and satisfaction of occupational performance, a survey of community participation, and a focus group.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Occupational therapy for cognitive impairment in stroke patients.
Gibson E, Koh CL, Eames S, Bennett S, et al · · 2022 · cited 29× · PMID 35349186 · DOI 10.1002/14651858.cd006430.pub3
Verify or expand the search:
- PubMed search for NCT04246385
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of CO-OP Group
Trials testing the same drug.
- NCT04681742 — Feasibility Testing of Cognitive Strategy Training in Post-Concussive Syndrome · NA · completed
Other recruiting trials for Cerebral Vascular Accident
Currently open trials in the same condition.
- NCT06191549 — Brain Stimulation Enhance Post-stroke Walking Survivors and Healthy Adults · NA · active not recruiting
- NCT05180812 — Safety and Feasibility of ExoNET · NA · active not recruiting
Other Shirley Ryan AbilityLab trials
Trials by the same sponsor.
- NCT07434492 — Smart AFO and 5-Azacitidine to Enhance Mobility in Children With Cerebral Palsy · Phase 2 · not yet recruiting
- NCT07433023 — tSCS and 5-Azacitidine for Enhanced Motor Outcomes in Cerebral Palsy · Phase 2 · not yet recruiting
- NCT06999213 — Lower Limb ExoNET: Development and Evaluation for Gait Assistance With Stroke Survivors · EARLY_PHASE1 · not yet recruiting
- NCT07032753 — Neuromusculoskeletal Interface for Bionic Arms · NA · not yet recruiting
- NCT07223710 — Improving Walking After Spinal Cord Injury · Phase 1, PHASE2 · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04246385 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Shirley Ryan AbilityLab
- Last refreshed: 17 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04246385.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing